Net profit of Marksans Pharma declined 34.29% to Rs 58.32 crore in the quarter ended June 2025 as against Rs 88.75 crore during the previous quarter ended June 2024. Sales rose 4.97% to Rs 619.99 crore in the quarter ended June 2025 as against Rs 590.62 crore during the previous quarter ended June 2024.
Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
Sales | 619.99 | 590.62 | 5 |
OPM % | 16.15 | 21.75 | - |
PBDT | 99.70 | 140.46 | -29 |
PBT | 76.60 | 120.02 | -36 |
NP | 58.32 | 88.75 | -34 |